The importance of the RET gene in thyroid cancer and therapeutic implications
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.nature.com/articles/s41574-021-00470-9.pdf
Reference134 articles.
1. Schlumberger, M., Carlomagno, F., Baudin, E., Bidart, J. M. & Santoro, M. New therapeutic approaches to treat medullary thyroid carcinoma. Nat. Clin. Pract. Endocrinol. Metab. 4, 22–32 (2008).
2. Markham, A. Selpercatinib: first approval. Drugs 80, 1119–1124 (2020).
3. [No authors listed] FDA approves selpercatinib; pralsetinib may soon follow. Cancer Discov. 10, OF1 (2020).
4. Takahashi, M., Ritz, J. & Cooper, G. M. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42, 581–588 (1985). This article describes the first isolation of RET as well as the first demonstration of its oncogenic activity.
5. Ishizaka, Y. et al. Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene 4, 1519–1521 (1989).
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Recent advances in the investigation of fusion RNAs and their role in molecular pathology of cancer;The International Journal of Biochemistry & Cell Biology;2024-03
2. TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer;Frontiers in Oncology;2024-01-19
3. Enhancer‐activated RET confers protection against oxidative stress to KMT2A‐rearranged acute myeloid leukemia;Cancer Science;2024-01-16
4. Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance;Drug Resistance Updates;2024-01
5. Pathology and new insights in thyroid neoplasms in the 2022 WHO classification;Current Opinion in Oncology;2023-11-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3